We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications.
- Authors
Zhu, Xinqing; Al-Danakh, Abdullah; Zhang, Lin; Sun, Xiaoxin; Jian, Yuli; Wu, Haotian; Feng, Dan; Wang, Shujing; Yang, Deyong
- Abstract
Renal cell carcinoma (RCC) is one of the most prevalent malignant tumors of the urinary system, accounting for around 2% of all cancer diagnoses and deaths worldwide. Clear cell RCC (ccRCC) is the most prevalent and aggressive histology with an unfavorable prognosis and inadequate treatment. Patients' progression-free survival is considerably improved by surgery; however, 30% of patients develop metastases following surgery. Identifying novel targets and molecular markers for RCC prognostic detection is crucial for more accurate clinical diagnosis and therapy. Glycosylation is a critical post-translational modification (PMT) for cancer cell growth, migration, and invasion, involving the transfer of glycosyl moieties to specific amino acid residues in proteins to form glycosidic bonds through the activity of glycosyltransferases. Most cancers, including RCC, undergo glycosylation changes such as branching, sialylation, and fucosylation. In this review, we discuss the latest findings on the significance of aberrant glycans in the initiation, development, and progression of RCC. The potential biomarkers of altered glycans for the diagnosis and their implications in RCC have been further highlighted.
- Subjects
RENAL cell carcinoma; GLYCOSYLATION; AMINO acid residues; CANCER cell growth; POST-translational modification; CELL migration
- Publication
Cells (2073-4409), 2022, Vol 11, Issue 16, p2598
- ISSN
2073-4409
- Publication type
Article
- DOI
10.3390/cells11162598